The synthesis and structure-activity relationships of novel 4-(imidazoyl-1-yl)butanamide derivatives as antimuscarinic activity agents were reported by the Kyorin Discovery Research group.
thetic route to quaternary N-glucuronide 2 from methyl 2,3,4-tri-O-benzoyl-1-methanesulfonyl-a -D-glucopyranuronate 9 as a glycosyl donor is shown in Chart 2. 1,2,3,4-tetra-O-benzoyl-b-D-glucopyranouronate 8, as a starting material, was synthesized from D-(ϩ)-glucurono-3,6-lacton by applying the reported method. 4) 8 was treated with methansulfonic acid in CH 2 Cl 2 to afford a-methansulfonate 9 in 49% yield. The glycosidation reaction between 1 and 9 was carried out in CHCl 3 to provide 10 in 41% yield, and also stereoselectivity was only obtained for the single b-isomer. Deprotection and hydrolysis of the methyl ester afforded ammonium N-glucuronaide 2 as inner salt after HP-20SS resin treatment.
Synthesis of Imidazolidine Dion 3
The synthesis of the metabolite 3 is outlined in Chart 3. N-(1-Aminoethyl)benzamide hydrochloride 11, prepared according to Carotti's method, 5) was transformed to 12 on treatment with chloroacethyl chloride followed by cyclization and protection by the Boc group in 30% yield (3 steps). The ring oxidation re- Ichiro action of 12 was achieved by using bromination with N-bromosuccinimide (NBS) followed by pyridinium dichromate (PDC) treatment to give imidazolidinone 13 in 50% yield. Debenzoylation of 13 with n-butylamine as a benzoyl group accepter under high-dilution condition in CH 3 CN at 0°C gave imidazolidinone 14. The obtained 14 was reacted with 4-bromo-2,2-diphenylbutyronitrile in the presence of NaH to afford the N-alkyl derivative 15, which was subsequently treated with trifluoroacetic acid in CH 2 Cl 2 and hydration of the CN group by using N,N-diethylhydroxylamine 6) to furnish the desired 4,5-dioxoimidazolidine compound 3 as a white powder in 41% yield (2 steps).
Synthesis of the Metabolites of 4-(2-Methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide (KRP-197/ONO-8025)
Synthesis of 4, 5, 6 and 7 The synthesis of the metabolite (4-7) from 4-amino-2-diphenylbutanamide 16 7) as a key intermediate is shown in Chart 4. The reaction of 16 and oxamic acid in the presence of 1-ethyl-3-[3-(diethylamino)-propyl]carbodiimide hydrochloride (EDC-HCl)/1-hydroxybenzotriazole monohydrate (HOBt-H 2 O) gave 4 in 35% yield. The reaction of 16 and ethyl chlorooxoacetate in the presence of Et 3 N gave oxalamic acid ester congener 17 (67%), which was treated with aqueous Na 2 CO 3 afforded 5 (63%). The coupling reaction of 16 and N-(benzyloxycarbonyl)glycine followed by consecutive catalytic hydrogenolysis and acetylation gave 6 in overall 47% yield. Amidine derivative 7 was synthesized from 16 with S-benzyl thioacetimidate hydrobromide 8) in 61% yield. These synthetic compounds (2-7) were identical with the proposed metabolite structure on the basis of the MS, 1 H-NMR and HPLC comparisons. The configuration at the anomeric position of the glucuronic acid moiety of 2 was determined by using 1 H-NMR analysis as shown in Chart 5. A doublet at d 5.52 in the 1 H-NMR spectrum was assigned to the anomeric proton (C 1 -H) of the glucuronic acid moiety and the coupling constant of 8.3 Hz confirmed the banomeric assignment (J values for a and b-anomers of glucuronides are in the range 2 to 4 Hz and 7 to 10 Hz, respectively 9) by a heteronuclear multiple bond connectivity (HMBC) spectrum, which demonstrated connectivity among C 5 of the imidazole ring and the anomeric proton (C 1 -H), C 4 of the imidazole ring and 4Ј-methyene proton of the butanamide moiety individually was consistent with the above structure (Chart 5).
The antimuscarinic activity of the compounds was evaluated in vitro, although all of these compounds were not active. Therefore, it is suggested that the metabolites of 1 do not play a crucial role in the urinary incontinence therapy.
Experimental
Melting points were determined with a Yanagimoto micromelting point apparatus and are uncorrected. Elemental analyses are within Ϯ0.3% of the theoretical values and were determined by a Yanaco CHN coder MT-5. Infrared spectra were recorded with a JASCO FT/IR-5300 spectrometer. Mass spectrometry (MS) and high-resolution MS (HR-MS) were performed with JEOL JMS SX-102A or JEOL JMS-T100LP mass spectrometer. C-NMR spectra were obtained on a JEOL EX-400 (400 MHz) spectrometer. Spectra were run in either CDCl 3 or DMSO-d 6 using TMS as internal standard, or in D 2 O using TSP as internal standard. Splitting patterns are indicated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad peak. Thin-layer chromatography (TLC) plates (Merck: silica gel 60 F254, 0.25 mm, Art 5715) were used for TLC analysis. Columm chromatography was performed with silica gel (Merck: silica gel 60 with particle size 0.040-0.063 mm). 4 mmol) in anhydrous CH 2 Cl 2 (300 ml), was added methansulfonic acid (55.8 g, 581 mmol), and the whole mixture was stirred for 45 min at room temperature. The reaction was quenched with 5% aqueous sodium bicarbonate (1400 ml). The organic layer was separated, and the aqueous layer was extracted two times with CH 2 Cl 2 . The combined organic solution was washed with water, dried over sodium sulfate (Na 2 SO 4 ), and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (CH 2 Cl 2 : hexane : AcOEtϭ10 : 5 : 1) and recrystallized from CH 2 Cl 2 -hexane to give a colorless solid 9 (20.6 g, 49%). 9: mp 139-140°C (dec. 
1-(3-Carbamoyl-3,3-diphenylpropy)-3-(2,3,4-tri-O-benzoyl-6-methyl-
142 mmol) and 9 (10.0 g, 16.7 mmol) in anhydrous CHCl 3 (500 ml) was refluxed for 13 h under argon. After cooling, the solvent was removed under reduced pressure. The residue was diluted with CH 2 Cl 2 and 1 M HCl. The organic layer was removed, and the aqueous layer was extracted with CH 2 Cl 2 . The combined organic solution was washed with 1 M HCl, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (CH 2 Cl 2 : MeOHϭ20 : 3) and recrystallized from CH 2 Cl 2 -hexane to give the title compound 10 as a pale grayish powder (5.82 g, 41%): 10: mp 164-167°C (dec. 
1-[3-(3-Carbamoyl-3,3-diphenyl)propyl-2-methyl-1-imidazolinio]-1-deoxy-b b-D-glucopyranuronate Hydrate (2)
To a solution of 10 (63.0 g, 73.4 mmol) in MeOH (2520 ml) was added 1 M NaOH (50 ml) over 30 min at Ϫ62 to Ϫ54°C. After the addition, the cooling bath was removed. The resulting solution was stirred for 30 min at 0°C and at room temperature for 30 min. The reaction mixture was neutralized with 6 M HCl and then the solvent was removed under reduced pressure. The residue was dissolved in water (600 ml), washed three times with CH 2 Cl 2 (300 mlϫ3). The aqueous layer was concentrated under reduced pressure. The residue was purified by synthetic adsorbed beads DIAION HP-20SS column chromatography (H 2 O : MeOH (gradient elution, 10 : 0-2 : 1)). The residual crystals were recrystallized two times from 2-propanol/water to give the title compound 2 as a colorless solid (32.4 g, 85% 1-Benzoyl-3-(tert-butoxycarbonyl)-2-methyl-1,3-imidazolidin-4-one (12) An ice-cooled suspension of N-(1-aminoethyl)benzamide hydrochloride 11 5) (47.2 g, 235 mmol) in anhydrous N,N-dimethylformamide (DMF, 35 ml) was treated with diisopropylethylamine (98.2 ml, 564 mmol) for 1 h, and then chloroacetylchoride (22.4 ml, 282 mmol) was added dropwise to the above reaction mixture over a period of 30 min. After the addition, the reaction mixture was stirred under ice cooling for 2 h and concentrated under reduced pressure. The residue was dissolved in CH 2 Cl 2 (1500 ml), washed with water, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was triturated with Et 2 O to give N-{1-[(chloroacetyl)-amino]ethyl}benzamide (29.8 g) as a crude product. The crude product (28.9 g, 120 mmol) was dissolved in anhydrous DMF (35 ml). To this solution was added NaH (60% dispersion in mineral oil, 14.4 g, 360 mmol) at 0°C, and the reaction mixture was stirred for 4 h at ambient temperature. The reaction was quenched with AcOH (30 ml). After being stirred for 30 min at room temperature, the mixture was allowed to stand overnight. The reaction mixture was concentrated under reduced pressure. The residue was diluted with CH 2 Cl 2 (300 ml) and water (100 ml). The organic layer was removed and the aqueous layer was extracted four times with CH 2 Cl 2 . The combined organic solution was washed with brine, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue (19.8 g) was dissolved in anhydrous CH 3 CN (485 ml). Di(tert-butyl)dicarbonate (Boc 2 O, 23.3 g, 107 mmol) and 4,4-dimethylaminopyridine (DMAP, 593 mg, 4.85 mmol) were added to above solution, and the reaction mixture was stirred for 1 h at room temperature. The reaction mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane : AcOEtϭ2 : 1) and triturated with petroleum ether (50 ml). The precipitate was collected by filtration, dried under vacuum to give the title compound 12 as a white powder (20.0 g, 30%). 12: mp 139-141°C. 
1-Benzoyl-3-(tert-butoxycarbonyl)-2-methyl-1,3-imidazolidine-4,5-dione (13)
A mixture of 12 (19.2 g, 63.0 mmol), N-bromosuccinimide (NBS, 12.3 g, 69.3 mmol), benzoyl peroxide (10.0 mg) and tetrachloromethane (315 ml) was refluxed for 30 min. After cooling, the reaction mixture was washed with saturated aqueous sodium bicarbonate (200 ml), saturated aqueous sodium aqueous hydrogen sulfite (520 ml) and water (50 ml), dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was dissolved in CH 2 Cl 2 (315 ml), and pyridinium dichromate (PDC, 47.4 g, 126 mmol) was added. The reaction mixture was stirred for 20 min at room temperature. The insoluble part was removed by filtration with the aid of a celite bed and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane : AcOEtϭ 2 : 1) and triturated with pentane. The resulting precipitate was collected by filtration, and dried under vacuum to give the title compound 13 as a white powder (10.1 g, 50% 
3-(tert-Butoxycarbonyl)-2-methyl-1,3-imidazolidine-4,5-dione (14)
A solution of n-buthylamine (2.27 g, 31.0 mmol) in CH 3 CN (155 ml) was added dropwise to an ice-cooled solution of 13 (9.87 g, 31.0 mmol) in CH 3 CN (1550 ml) over a period of 2 h. After the addition, the reaction mixture was concentrated under reduced pressure. The residue was triturated with petroleum ether (30 ml). The precipitate was collected by filtration, dried over vacuum to give the title compound 14 as a white powder (6.07 g, 91%). 14: mp 160-162°C (dec. 4-(2-Methyl-4,5-dioxoimidazolidin-1-yl)-2,2-diphenylbutyronitrile (15) An ice-cooled solution of 14 (6.00 g, 28.0 mmol) in anhydrous DMF (35 ml) was treated with NaH (60% dispersion in mineral oil, 1.34 g, 33.6 mmol). After stirring for 30 min at the same temperature followed by stirring for 1 h at room temperature, 4-bromo-2,2-diphenylbutyronitrile (84.1 g, 280 mmol) was added to the solution, and heated at 80°C for 2 h. After cooling, the reaction mixture was concentrated under reduced pressure. The residue was dissolved in AcOEt (500 ml), washed with water, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was dissolved in CH 2 Cl 2 (500 ml). Trifluoroacetic acid (100 ml) was added to the above ice-cooled solution, and the reaction mixture was stirred for 4 h at room temperature. The reaction mixture was concentrated under reduced pressure, and the residue was dissolved in CH 2 Cl 2 (280 ml), washed with saturated aqueous sodium bicarbonate (200 mlϫ2) and water (50 ml), dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was triturated with ether (300 ml). The precipitate was collected by filtration, dried under vacuum to give the title compound 15 as a white powder (6.53 g, 70% , 1.21 g, 6 .31 mmol). After being stirred for 2.5 h at room temperature, the mixture was allowed to stand overnight at the same temperature. The reaction mixture was poured into water (150 ml), extracted two times with AcOEt and the combined organic layer was washed with water, dried over Na 2 SO 4 , and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (AcOEt) and recrystallized from MeOH-H 2 O to give the title compound 4 as a white solid (0.71 g, 35%). 4: mp 178-180°C. N-(3-Carbamoyl-3,3-diphenylpropyl) oxamic Acid (17) To a solution of 16 (6.77 g, 26.6 mmol) in CH 2 Cl 2 (200 ml) containing triethylamine (3.00 g, 29.6 mmol) was added dropwise ethyl chlorooxoacetate (4.00 g, 29.3 mmol) at 0°C. After the addition, the reaction mixture was stirred at room temperature for 10 min. The reaction mixture was diluted with CH 2 Cl 2 (200 ml), washed with water (200 ml) and saturated aqueous sodium bicarbonate (200 ml), dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was triturated with EtOH (10 ml), and the precipitate was collected by filtration, and dried under vacuum to give the title compound 17 as a white powder (7.29 g, 67% Carbamoyl-3,3-diphenylpropyl) oxamic Acid (5) A suspension of 17 (10.6 g, 30.0 mmol) and 10% aqueous sodium carbonate (106 ml) in EtOH (500 ml) was refluxed for 4 h. After cooling, the reaction mixture was concentrated under reduced pressure. Water (800 ml) was added to the residue and the insoluble part was removed by filtration. The filtrate was washed with CH 2 Cl 2 (400 ml) and AcOEt (400 ml), and neutralized with 2 M HCl. The precipitate was collected by filtration, and purified by recrystallization from EtOH, dried under vacuum at 100°C to give the title compound 5 as a white solid (6.16 g, 63% -N-(3-carbamoyl-3,3-diphenylpropyl) acetamide (6) To a solution of 16 (509 mg, 2.0 mmol), N-(benzyloxycarbonyl)glycine (418 mg, 2.00 mmol) and HOBt-H 2 O (270 mg, 2.00 mmol) in CH 2 Cl 2 (10 ml) were added EDC-HCl (383 mg, 2.0 mmol) and triethylamine (558 ml, 4.00 mmol). After being stirred for 8 h at room temperature, the mixture was allowed to stand overnight at the same temperature. The reaction mixture was diluted with AcOEt, washed with 1 M NaOH, 1 M HCl and water, dried over Na 2 SO 4 , and concentrated under reduced pressure to give crude benzyl [N-(3-carbamoyl-3,3-diphenylpropyl)carbamoylmethyl]carbamic acid as a colorless solid. The obtained carbamic acid derivative was dissolved in THF (16 ml), 7.5% Pd-C (162 mg) and acetic anhydride (189 ml, 2.00 mmol) were added. The reaction mixture was stirred for 6 h at room temperature under hydrogen atmosphere, and then DMF was added until the resulting precipitate was dissolved. The catalyst was removed by filtration through celite, and the filtrate was concentrated. The residue was recrystallized from EtOH to give the title compound 6 as a white solid (320 mg, 47%). 6: mp 214-215°C. 
N-(3-

2-Acetylamino
4-[(Acetimidoyl)amino]-2,2-diphenylbutanamide (7) S-Benzyl thioacetimidate hydrobromide
8) (4.92 g, 20.0 mmol) was added in small portions to an ice-cooled mixture of 16 (5.09 g, 20.0 mmol) and EtOH (100 ml), and the solution was stirred for 2 h at the same temperature. The reaction mixture was concentrated under reduced pressure, and the residue was triturated with EtOH (50 ml). The resulting precipitates were collected by filtration, and purified by recrystallization (EtOH) to give the hydrobromide of 7 (3.87 g). The obtained hydrobromide 7 (2.63 g, 7.00 mmol) was suspended in water (53 ml) and cooled at 5°C. 1 M NaOH (7.7 ml, 7.70 mmol) was added to the above mixture, and the mixture was stirred for 2 h at ambient temperature. The resulting precipitate was collected by filtration, and purified by recrystallization (CH 3 CN/IPE) to give the title compound 7 as a white powder (1.26 g, 61%). 7: mp 166-167°C. 
